Enzon Pharmaceuticals, Inc. (OTCMKTS: ENZN) related to its merger with Viskase Companies, Inc. Upon completion of the proposed transaction, Viskase shareholders are expected to own 55% of the combined company.
Enzon Pharmaceuticals, Inc. (OTCMKTS: ENZN) related to its merger with Viskase Companies, Inc. Upon completion of the proposed transaction, Viskase shareholders are expected to own 55% of the combined company.